Specializing In:
Hodgkin and non-Hodgkin lymphoma T-cell lymphoma Cutaneous (skin) lymphoma T-LGL, Chronic lymphocytic leukemiaAbout Paola Ghione
Biography:
I am a Hematologist Oncologist specializing in the treatment of lymphoma and mature lymphoid leukemia. I dedicate my work to understanding more about these diseases, and find new strategies to treat people that have them. After my first specialization in hematology and oncology, I have decided to pursue additional training specifically in lymphoma with some of the top specialists in the field, and I have performed research both clinically and translational, with the help of our labs.
Positions
Roswell Park Comprehensive Cancer Center
- Assistant Professor of Oncology
- Lymphoma Section, Department of Medicine
Jacobs School Of Medicine And Biomedical Sciences, State University of New York at Buffalo
- Assistant Professor of Oncology
Background
Education and Training:
- 2011 - MD - Medicine and Surgery, University of Torino, Italy
Residency:
- 2012-2017 - Internal Medicine, Hematology and Oncology, University of Torino, Italy
Fellowship:
- 2017-2020 - Advanced Oncologic Fellowship in Lymphoma, with focus on T cell and cutaneous lymphoma, Memorial Sloan Kettering Cancer Center, New York, NY
Board Certification:
- 2017 - Italian Board Certification in Hematology and Oncology
Professional Memberships:
- Member of NCCN guidelines for T cell lymphoma
- Steering Committee Emerging Woman in Lymphoma member (WiL Snowdome Foundation)
- Member American Society of Clinical Oncology
- Associate Member American Society of Hematology
- Member International Society for Cutaneous Lymphoma
- Member Italian Lymphoma Foundation
- Member European Hematology Association
Honors & Awards:
- 2019 - Travel grant for 10 best abstracts, ICML, Lugano
- 2017-2018 - European Hematology Masterclass Mentee
- 2016 - Travel grant for young investigators - SIE (Italian society of Hematology)
- 2008-2009 - Erasmus program European Students Grant
Clinical Trials
Publications
T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma.
Paola Ghione, Promie Faruque, Neha Mehta-Shah, Venkatraman Seshan, Neval Ozkaya, Shakthi Bhaskar, James Yeung, Michael A Spinner, Matthew Lunning, Giorgio Inghirami, Alison Moskowitz, Natasha Galasso, Nivetha Ganesan, Carrie van der Weyden, Jia Ruan, H Miles Prince, Judith Trotman, Ranjana Advani, Ahmet Dogan, Steven Horwitz
Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population.
Paola Ghione, Shunan Qi, Brandon S Imber, Venkatraman Seshan, Alison Moskowitz, Natasha Galasso, Matthew Lunning, David Straus, Craig Sauter, Parastoo Dahi, Ahmet Dogan, Joachim Yahalom, Steven Horwitz
Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants
Peter G Cordeiro, Paola Ghione, Andy Ni, Qunying Hu, Nivetha Ganesan, Natasha Galasso, Ahmet Dogan, Steven M Horwitz
Final results of a phase II biomarker-driven study of ruxolitinib in relapsed and refractory T-cell lymphoma
Alison J Moskowitz, Paola Ghione, Eric D Jacobsen, Jia Ruan, Jonathan H Schatz, Sarah Noor, Patricia Myskowski, Helen Hancock, Theresa Davey, Obadi Obadi, Carlissa Onwasigwe, Nivetha Ganesan, Lauren Pomerantz, Christine Jarjies, Priyadarshini Kumar, Allison Sigler, Mark B Geyer, Ariela Noy, David J Straus, Travis Hollmann, Ahmet Dogan, Natasha Galasso, Giorgio Inghirami, David M Weinstock, Steven M Horwitz
Novel immunotherapies for T cell lymphoma and leukemia
Paola Ghione, Alison J Moskowitz, Nadia EK De Paola, Steven M Horwitz, Marco Ruella